PRECIGEN, INC. (PGEN)
$7.00-$0.19 (-2.64%) Today
Rutul R. Shah - OfficerRutul R. Shah - OfficerRutul R. Shah - OfficerRutul R. Shah - OfficerPrecigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 3,411 | $25K |
| Open-market sale | 16 | 1,333,677 | $7.95M |
| Option exercise | 22 | 1,197,476 | |
| Tax withholding / forfeiture | 5 | 22,481 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
67 Form 4 filings on record, the earliest from Dec 30, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Donald P. Lehr - Officer | Grant or award | Performance Stock Units | 54,000 | $0.00 | - | |
| Rutul R. Shah - Officer | Grant or award | Performance Stock Units | 125,000 | $0.00 | - | |
| Harry Thomasian Jr. - Officer | Grant or award | Performance Stock Units | 125,000 | $0.00 | - | |
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 15,000 | $4.60 | $69K | |
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 15,360 | $3.20 | $49K | |
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 10,645 | $4.65 | $49K | |
| Nancy H. Agee - Director | Option exercise | Common Stock | 126,760 | - | - | |
| Nancy H. Agee - Director | Option exercise | Restricted Stock Units | 126,760 | $0.00 | - | |
 Randal J. Kirk | Open-market purchase | 8.00% Series A Convertible Perpetual Preferred Stock | 25,000 | - | - | |
| Randal J. Kirk | Open-market purchase | Warrant to Purchase Common Stock | 16,666,667 | - | - |
This is as far as the anonymous view goes. Create a free account for all 67 PGEN filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jeffrey Kindler | Director | 185,000 | $1.37M | View on EDGAR | |
| Tennant Phil | Officer | 79,166 | $594K | View on EDGAR | |
| Shah Rutul R | Officer | 15,342 | $115K | View on EDGAR |
PRECIGEN, INC. (PGEN) had 18 insider filings in the last 90 days, with the most recent on 2026-08-29. The full record for PGEN runs to 67 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of PGEN was filed in the last 90 days, totaling $25K.
16 insider sales of PGEN were filed in the last 90 days, totaling $7.95M.
This page tracks PGEN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PGEN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
